Skip to main content

ChEMBL Tour 2014 - The Netherlands, Belgium, and Luxembourg

Last year Louisa Bellis toured the UK to present on and ChEMBL. The tour was well received and a large number of people that had not heard of ChEMBL were introduced to ChEMBL.

Following the success of the previous tour, Gerard van Westen (EMBL –EBI) is going to be doing a 2014 ChEMBL tour. This year’s tour will be going to the BeNeLux. For dates and locations see below. Please feel free to attend and meet up / chat on ChEMBL, contactable via email on gerardvw [at]

Current dates are as follows:

19th of May – Maastricht University
Host: Egon Willighagen
Time: 12.00-17.00
ChEMBL + Allosteric modulators

20th of May – Maastricht University
Host: Jos Kleinjans
Time: 09.00 - 11.30
ChEMBL + Advanced ChEMBL

20th of May – KU Leuven
Host: Pieter Annaert
Time: 14.00 -17.00

21th of May – KU Leuven
Host: Piet herdewyn
Time: 09.00 -10.00

21th of May – University of Luxembourg
Host: Reinhard Schneider
Time: 13.00 - 17.00
ChEMBL + Advanced ChEMBL

22nd of May – Universiteit Antwerpen
Host: Koen Augusteyns
Time: 15.00 - 17.00

26th of May – VU University Amsterdam & Universiteit van Amsterdam
Hosts: Chris de Graaf & Willem Stiekema
Time: 10.00 - 15.00
ChEMBL + Allosteric modulators

28th of May – University of Groningen
Host: Alexander Domling
Time: 14.00 - 17.00
ChEMBL + Advanced ChEMBL

6th of June – Utrecht University
Host:  Roland Pieters
Time: 09.00 - 12.00

6th of June – Universiteit Leiden
Host: Ad IJzerman
Time: 15.30 - 17.00

17th of June – Erasmus Medical Centre, Rotterdam
Host: Roland Kanaar
Time: 14.00 - 17.00

18th of June – Radboud University Nijmegen
Host: Tina Ritschel
Time: 13.30 - 15.00
ChEMBL + Allosteric modulators


Andy said…
I wish you a good trip, Gerard, and may you further increase the fame and glory of ChEMBL :-)! All the best, Andreas

Popular posts from this blog

ChEMBL 34 is out!

We are delighted to announce the release of ChEMBL 34, which includes a full update to drug and clinical candidate drug data. This version of the database, prepared on 28/03/2024 contains:         2,431,025 compounds (of which 2,409,270 have mol files)         3,106,257 compound records (non-unique compounds)         20,772,701 activities         1,644,390 assays         15,598 targets         89,892 documents Data can be downloaded from the ChEMBL FTP site: Please see ChEMBL_34 release notes for full details of all changes in this release: New Data Sources European Medicines Agency (src_id = 66): European Medicines Agency's data correspond to EMA drugs prior to 20 January 2023 (excluding vaccines). 71 out of the 882 newly added EMA drugs are only authorised by EMA, rather than from other regulatory bodies e.g.

New SureChEMBL announcement

(Generated with DALL-E 3 ∙ 30 October 2023 at 1:48 pm) We have some very exciting news to report: the new SureChEMBL is now available! Hooray! What is SureChEMBL, you may ask. Good question! In our portfolio of chemical biology services, alongside our established database of bioactivity data for drug-like molecules ChEMBL , our dictionary of annotated small molecule entities ChEBI , and our compound cross-referencing system UniChem , we also deliver a database of annotated patents! Almost 10 years ago , EMBL-EBI acquired the SureChem system of chemically annotated patents and made this freely accessible in the public domain as SureChEMBL. Since then, our team has continued to maintain and deliver SureChEMBL. However, this has become increasingly challenging due to the complexities of the underlying codebase. We were awarded a Wellcome Trust grant in 2021 to completely overhaul SureChEMBL, with a new UI, backend infrastructure, and new f

Accessing SureChEMBL data in bulk

It is the peak of the summer (at least in this hemisphere) and many of our readers/users will be on holiday, perhaps on an island enjoying the sea. Luckily, for the rest of us there is still the 'sea' of SureChEMBL data that awaits to be enjoyed and explored for hidden 'treasures' (let me know if I pushed this analogy too far). See here and  here for a reminder of SureChEMBL is and what it does.  This wealth of (big) data can be accessed via the SureChEMBL interface , where users can submit quite sophisticated and granular queries by combining: i) Lucene fields against full-text and bibliographic metadata and ii) advanced structure query features against the annotated compound corpus. Examples of such queries will be the topic of a future post. Once the search results are back, users can browse through and export the chemistry from the patent(s) of interest. In addition to this functionality, we've been receiving user requests for  local (behind the